Get the Stockscreener App
0.4459
6.83%
-0.0327
Pre-market:
.44
-0.0059
-1.32%
Nexalin Technology Inc stock is traded at $0.4459, with a volume of 119.57K.
It is down -6.83% in the last 24 hours and down -37.21% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$0.4786
Open:
$0.4738
24h Volume:
119.57K
Relative Volume:
0.46
Market Cap:
$8.32M
Revenue:
$174.80K
Net Income/Loss:
$-8.85M
P/E Ratio:
-0.6475
EPS:
-0.6887
Net Cash Flow:
$-4.37M
1W Performance:
-28.08%
1M Performance:
-37.21%
6M Performance:
-49.27%
1Y Performance:
-85.89%
1-Day Range:
$0.4448
$0.50
1-Week Range:
$0.4448
$0.68
52-Week Range:
$0.4448
$3.5399
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.4459 | 8.93M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Nexalin Technology Inc Stock (NXL) Latest News
Big Picture: Can Nexalin Technology Inc Equity Warrant deliver alphaEarnings Performance Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Nexalin Technology receives Nasdaq bid price deficiency notice - MSN
SEC Filings | Track, Search, and Analyze Public Company Disclosures - SECFilings.com
Decliners Report: Can Nexalin Technology Inc deliver consistent dividendsWeekly Trend Recap & Daily Volume Surge Signals - baoquankhu1.vn
Market Pulse: Will Nexalin Technology Inc benefit from geopolitical trendsQuarterly Growth Report & Technical Pattern Alert System - baoquankhu1.vn
Nexalin Launches NeuroCare, An AI Virtual Clinic for Brain Health Disorders - AIM Media House
Aug Drivers: Does Nexalin Technology Inc Equity Warrant have strong fundamentalsStop Loss & Verified High Yield Trade Plans - baoquankhu1.vn
Nexalin Technology stock rises after launching AI-powered virtual clinic By Investing.com - Investing.com Australia
Nexalin Technology stock rises after launching AI-powered virtual clinic - Investing.com
Nexalin Technology, Inc. Launches NeuroCare® Virtual Clinic Platform in Collaboration with UC San Diego to Enhance Brain Health Treatment Access and Monitoring - Quiver Quantitative
Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care - ChartMill
EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings - Benzinga
Nexalin Expands Peer-Reviewed Evidence For DIFS Non-Invasive Brain Stimulation - Nasdaq
Nexalin reports brain imaging studies validate its neurostimulation tech By Investing.com - Investing.com Nigeria
Nexalin reports brain imaging studies validate its neurostimulation tech - Investing.com
Nexalin Technology, Inc. Showcases Validation of DIFS™ Neurostimulation Technology Through Extensive Clinical Research - Quiver Quantitative
Nexalin Highlights its Expanding Body of Peer-Reviewed - GlobeNewswire
Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS™ Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation - The Manila Times
Rate Hike: Should I invest in Nexalin Technology Inc Equity Warrant before earningsJuly 2025 Catalysts & Low Drawdown Momentum Ideas - baoquankhu1.vn
CEO Moves: How is CRDA managing supply chain issuesWeekly Investment Report & AI Enhanced Trading Signals - baoquankhu1.vn
Is Nexalin Technology Inc. likely to announce a buyback2025 Price Targets & Scalable Portfolio Growth Methods - mfd.ru
Does Nexalin Technology Inc. Equity Warrant have strong fundamentalsAnalyst Downgrade & Verified Entry Point Signals - mfd.ru
What is Nexalin Technology Inc.’s book value per shareWeekly Stock Summary & Reliable Breakout Stock Forecasts - mfd.ru
Nexalin Technology receives Nasdaq listing status notification - Medical Buyer
Guidance Update: Is Nexalin Technology Inc a strong growth stock2025 Performance Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Aug Action: What are analysts price targets for Nexalin Technology Inc Equity WarrantJuly 2025 News Drivers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Aug Highlights: Is Nexalin Technology Inc stock forming a cup and handleJuly 2025 Breakouts & Technical Confirmation Alerts - baoquankhu1.vn
Nexalin receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com South Africa
Nexalin Faces Nasdaq Noncompliance Over Minimum Bid Price - TipRanks
Nexalin Technology Receives Nasdaq Warning for Non-Compliance with Minimum Bid Price - intellectia.ai
Nexalin receives Nasdaq minimum bid price deficiency notice - Investing.com
Nexalin Technology Receives Nasdaq Listing Status Notification - The Manila Times
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Earnings Report: Is Nexalin Technology Inc Equity Warrant stock a good dividend stockTrade Exit Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Aug Update: Does Nexalin Technology Inc have consistent dividend growth2025 Big Picture & Low Drawdown Investment Ideas - baoquankhu1.vn
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Earnings Risk: How cyclical is HWH International Inc.’s revenue streamTrade Analysis Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Trading Action: Is Nexalin Technology Inc Equity Warrant forming a double bottomJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Can Nexalin Technology Inc Equity Warrant outperform in the next rallyTake Profit & Weekly Top Stock Performers List - baoquankhu1.vn
Drug-free brain stimulation eases adult ADHD and calms overactive activity - Stock Titan
Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ - GlobeNewswire
Aug Sectors: Will Nexalin Technology Inc stock benefit from M AJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-01-10 20:28:51 - Улправда
HOKA Model Insights: Why Nexalin Technology Inc. stock attracts high net worth investorsPerformance Line Overview & support options for steady strides - Улправда
Is Nexalin Technology Inc. Equity Warrant stock undervalued vs historical averagesTraining Rotation Ideas & stability guidance for smoother miles - ulpravda.ru
Why Nexalin Technology Inc. Equity Warrant stock appeals to dividend seekers2025 Trading Volume Trends & Safe Swing Trade Setups - Улправда
Is Nexalin Technology Inc. stock a top pick in earnings season2025 EndofYear Setup & Daily Profit Focused Screening - Улправда
Why Nexalin Technology Inc. stock attracts high net worth investorsWeekly Market Outlook & High Accuracy Swing Trade Signals - Улправда
Nexalin Technology, Inc.Common Stock (NQ: NXL - FinancialContent
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - sctimes.com
Is Nexalin Technology Inc a good long term investmentFibonacci Retracement Levels & Free Technical Analysis and Insights - Early Times
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):